Mode
Text Size
Log in / Sign up

In Polish adults aged ≥40, circulatory and sensory diseases linked to higher polypharmacy categoriesTaking More Meds Does Not Mean You Are Sicker

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that circulatory and sensory diseases associate with higher polypharmacy in this Polish prevention cohort.

This exploratory cohort study included 151 adults aged ≥40 years engaged in the Polish Prophylaxis 40 PLUS prevention programme. The analysis assessed associations between baseline clinical characteristics and polypharmacy categories defined by the number of medications (5, 6, or ≥7 drugs). Bootstrap resampling (B = 200) was used to assess parameter stability.

Circulatory system diseases (ICD-10 I) were associated with higher odds of belonging to a higher polypharmacy category, with an effect size of OR 2.3–2.6. Normalisation of previously irregular heart rhythm also predicted a higher medication burden (OR 6.0–8.4). Sensory system diseases (ICD-10 H) showed a positive association with polypharmacy, whereas nervous-system diseases (ICD-10 G) demonstrated an inverse relationship.

Baseline diastolic blood pressure was negatively associated with medication count (OR 0.93–0.95 per mmHg). Educational attainment showed an exploratory positive association. Absolute numbers, p-values, and confidence intervals were not reported for these outcomes.

Safety data, including adverse events and tolerability, were not reported. Key limitations include the exploratory nature of the study and limited knowledge regarding polypharmacy patterns in this specific population. The study does not establish causality. Practice relevance emphasizes integrating structured medication review, targeted deprescribing, and equitable preventive pharmacotherapy into cardiovascular prevention pathways.

The Hidden Reason for More Pills

Imagine walking into a doctor's office feeling tired and worried. You have high blood pressure and a history of heart trouble. Your doctor prescribes a new list of pills. You might think, "I have so many conditions now." But what if those extra pills are actually a sign of progress?

This is the surprising twist in new research from Poland. Doctors usually assume that taking many medicines means a patient is very sick. However, this study found something different in middle-aged adults.

Many people worry about "polypharmacy," which is the medical term for taking many drugs at once. This often happens in older adults. But fewer studies look at people in their 40s and 50s.

These middle-aged adults are often in prevention programs. They try to stop lifestyle diseases like heart disease before they get worse. The problem is that as they get better, they sometimes end up on more medication. This confuses patients who think more pills equal more sickness.

For a long time, doctors believed that a long list of medicines meant a patient had many different diseases. This is called multimorbidity. The logic was simple: more diseases need more pills.

But here's the twist. This new study shows that in heart care, a longer list of pills can mean the opposite. It can mean a doctor is actively fixing a dangerous heart rhythm. When a heart beats irregularly, it needs specific treatment. Once that rhythm is fixed, the patient might take more drugs to keep it stable.

Think of your heart like a traffic system. Sometimes, the traffic lights (your heart rhythm) get confused. Cars crash into each other (heart attacks or strokes). Doctors use medicine to reset the lights.

When the lights are reset, the system becomes more complex. You need more specific instructions to keep the traffic flowing smoothly. This is why a patient with a fixed heart rhythm might take more pills than someone with a simple, steady heartbeat. The extra pills are the price of a working system.

Researchers looked at 151 adults aged 40 and older in a Polish national health program. They sorted these people into three groups based on how many pills they took: five, six, or seven or more.

The team checked their age, lifestyle habits, blood pressure, and medical history. They also looked at what diseases they had, using a standard list called ICD-10. They used a special math method to see which factors truly predicted a higher number of pills.

The most important discovery involved the heart. People with diseases of the circulatory system were much more likely to be on a higher number of medications. This makes sense because heart disease requires careful management.

Even more surprising was the link to heart rhythm. When doctors successfully fixed an irregular heart beat, the patient's medication count jumped significantly. The odds of taking more drugs went up by six to eight times. This proves that treating the rhythm adds to the pill count.

But there's a catch. Not all diseases added to the pill list. Interestingly, certain nervous system issues were linked to taking fewer drugs. This suggests that not every extra diagnosis requires an extra pill. The system is smarter than we thought.

This research fits into a bigger picture of modern medicine. It shows that we must stop judging patients by how many pills they take. A long list does not automatically mean a patient is failing or over-medicated.

Instead, it means the treatment plan is complex. Doctors are managing multiple moving parts to keep a patient safe. This requires a team approach, often involving several specialists working together to manage heart health.

If you are in a prevention program or managing heart disease, do not panic if your pill count goes up. Talk to your doctor about why each new medicine is needed. Ask if it is fixing a specific problem like a heart rhythm.

You should never stop taking medication without asking. But understanding the "why" can reduce your anxiety. It helps you see your treatment as a tool for stability, not just a burden.

This study has some limits. It only looked at people in one specific national program in Poland. The group was relatively small, with only 151 participants. Also, the results come from a specific time and place. We do not know if this applies to everyone everywhere.

The next step is to test these ideas in larger groups of people. Researchers need to see if these patterns hold true in the United States and other countries.

We also need to teach doctors and patients to look at the "why" behind the pill count. Future care plans should include regular reviews to make sure every medicine has a clear job. This ensures that taking more pills always means getting better, not just getting sicker.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundThe prevalence of polypharmacy has been rising worldwide, most studies focuses on older adults. However, little is known about patterns and determinants of polypharmacy in middle-aged individuals engaged in structured national prevention programmes. This exploratory study examines how clinical characteristics, comorbidity structure, and system-level actions relate to increasing medication burden in participants of the Polish Prophylaxis 40 PLUS prevention programme, which focuses on the prevention and early detection of lifestyle-related (civilization) diseases, particularly cardiovascular conditions.MethodsA cohort of 151 adults aged ≥40 years was stratified into three ordinal polypharmacy categories (5, 6, ≥7 drugs). Patients demographics, lifestyle behaviours, blood-pressure measures, ICD-10 comorbidity blocks, and indicators of medical actions were analysed. Ordinal proportional-odds regression (forward and backward stepwise selection) was performed with multimorbidity included as an adjustment covariate. Bootstrap resampling (B = 200) assessed parameter stability.ResultsCirculatory system diseases (ICD-10 I) were consistently associated with higher odds of belonging to a higher polypharmacy category (OR 2.3–2.6). Normalisation of previously irregular heart rhythm strongly predicted higher medication burden (OR 6.0–8.4). Sensory system diseases (ICD-10 H) were also positively associated with polypharmacy, whereas nervous-system diseases (ICD-10 G) showed an inverse relationship. Higher baseline diastolic blood pressure was negatively associated with medication count (OR 0.93–0.95 per mmHg). Educational attainment demonstrated a weaker, exploratory positive association. Bootstrap analysis confirmed the robustness of the main predictors (ICD-10 I, ICD-10 G/H, heart-rhythm change, baseline DBP).ConclusionIn middle-aged adults within a Polish national prevention programme, polypharmacy reflects treatment intensity and system-level complexity rather than multimorbidity alone. Cardiovascular disease, rhythm-control interventions, and multi-specialty care were associated with higher medication burden. These findings highlight the importance of integrating structured medication review, targeted deprescribing, and equitable preventive pharmacotherapy into cardiovascular prevention pathways.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.